MCRB
Seres Therapeutics Inc
Price:  
6.61 
USD
Volume:  
124,619.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MCRB Stock Forecast & Price Target

MCRB Stock Price Forecast

The average stock forecast for Seres Therapeutics Inc (MCRB) in the next 12 months is 22.44 USD. This price target corresponds to an upside of 247.37%. The range of stock forecasts for MCRB is 22.22 - 23.10 USD. Based on the ratings of 7 analysts, the consensus recommendation for MCRB is BUY.
Target Low Average Median High
Price (USD) 22.22 22.44 22.44 23.10
Upside 243.96% 247.37% 247.37% 257.59%

Recommendation Trends

The latest consensus rating for MCRB is "BUY". This is the average recommendation of 7 analysts: 0 strong sell, 0 sell, 1 hold, 4 buy, 2 strong buy. In the previous period, 7 analysts also majorly recommmended "BUY" for MCRB.

MCRB Financial Stock Forecast

Revenue This Year
0.73M
-7.44%
from 0.79M
Revenue Next Year
0.73M
-%
from 0.73M
EPS This Year
-9.28
-1,677.40%
from 0.59
EPS Next Year
-10.38
11.86%
from -9.28